Nikolaus Marx

Cardiology — Universitätsklinikum Aachen, Germany

LeadR Profile

Nikolaus Marx Universitätsklinikum Aachen Germany
3 071 ScienceLeadR Reputation 3071
Network Map

Cardiology

Subspecialties: Endocrinology - Nephrology - Biochemistry

Full career Last 3 years

Main Topics

Publications and Clinical Studies

Publications Clinical Studies

Organizations

Source: Pubmed

Universitätsklinikum Aachen

Publications Synthesis

Source: Pubmed

Number : 886

Citations

Citations: 44 377 1st author: 59 Last author: 118 Unique author: 42

Main journals

Eur Heart J 107
Dtsch Med Wochenschr 29
Clin Res Cardiol 25
Cardiovasc Diabetol 23
Circulation 23

Best Journals

Eur Heart J 35
Circulation 7
Lancet Diabetes Endocrinol 5

Breakdown by type

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
The year in cardiovascular medicine 2025: the top 10 papers in diabetes and metabolic disorders.
diabetes mellitus
Eur Heart J Top journal20261
PCSK9 inhibitor treatment and outcomes in patients with atherosclerotic cardiovascular disease but without prior ischaemic events: an observational study.
mortality, cholesterol, ldl, ischemic stroke, stroke, myocardial infarction, cardiovascular diseases, cardiology, therapeutics
Eur Heart J Top journal20260
1-Phosphatidylinositol 3-Phosphate 5-Kinase Inhibition by Apilimod Promotes an Adipocyte-Like Vascular Smooth Muscle Cell Phenotype and Prevents Arterial Calcification.
cells, extracellular vesicles, muscle cells, muscles, muscle, smooth, phenotype, collagen, arteries, phosphatidylinositols, adipocytes, muscle, smooth, vascular, vascular calcification, myocytes, smooth muscle, fatty acids
Circ Res20260
Prevalence and Predictors of High Inflammatory Risk in Heart Failure Subtypes: Findings From the Global POSEIDON Study.
heart failure, heart, c-reactive protein, heart failure, diastolic, kidney, heart failure, systolic, prevalence, obesity
Eur J Heart Fail20260
European Journal of Heart Failure International Expert Position Paper Utilisation, Optimisation, and Clinical Benefits of Steroidal Mineralocorticoid Receptor Antagonists in Heart Failure with a Reduced Ejection Fraction.
heart failure, heart, receptors, mineralocorticoid, eplerenone, heart failure, systolic, therapeutics, mineralocorticoids, mineralocorticoid receptor antagonists
Eur J Heart Fail20260

Clinical Studies 33

Source: ClinicalTrials

Synthesis

Principal Investigator: 5 Study Director: 1

By phase:

N/A 18
Phase 3 9
Phase 4 3
Phase 2 2
Phase 1 1

By status:

Completed 26
Terminated 3
Active not recruiting 1
Recruiting 1
Suspended 1
Unknown 1

By type:

Interventional 22
Observational 11

By Monocentric/Multicentric:

monocentric 17
multicentric2to4 2
multicentric5to9 0
multicentricup10 14

Main Topics

Cardiovascular Diseases 16
Nutritional and Metabolic Diseases 14
Endocrine System Diseases 11
Respiratory Tract Diseases 3
Female Urogenital Diseases and Pregnancy Complications 2
Male Urogenital Diseases 2

Cohort/Consortium Investigators 1

Ongoing Clinical Trials

Ongoing trial started since 2021, where this expert is an investigator

Source: ClinicalTrials

Study Phase Status Start
Non invasive Differentiation of Supraventricular Tachyarrhythmia
NCT06061120 — arrhythmias, cardiac, atrial fibrillation, tachycardia, therapeutics, tachycardia, supraventricular, electrocardiography
N/ARecruiting2021

LeadR Networks

Main global connection map

Source: Pubmed Source: ClinicalTrials